Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
ARM-X: an adaptable mesenchymal stromal cell-based vaccination platform suitable for solid tumors
Jean Pierre Bikorimana
Nehme El-Hachem
Gabrielle A. Mandl
Daniela Stanga
Jamilah Abusarah
Roudy Farah
Marina P. Gonçalves
Perla Matar
Malak Lahrichi
Sebastien Talbot
Moutih Rafei
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1186/s13287-025-04465-5
Jul 15, 2025
Version published to 10.21203/rs.3.rs-5828115/v1 on Research Square
Apr 23, 2025
Related articles
Glycyrrhiza Polysaccharide-Adjuvanted Liposomal Vaccine Potentiates Tumor Immunotherapy through Lymph Node-Targeted Modulation of the DC-T Cell Axis
This article has 13 authors:
Xiaopan Yao
Keqing Zhang
XiaoKun Zhang
Shengxin Lu
Jinyuan Hu
Yuexuan Wang
Jiayi Lin
Ye Wu
Weidong Zhang
Hongzhuan Chen
Xia Liu
Bei Wang
Xin Luan
In vivo
screening of TCR-based chimeric antigen receptors for improved anti-tumor functionality
This article has 5 authors:
Andreas Zingg
Reto Ritschard
Helen Thut
Gregor Hutter
Heinz Läubli
Enhanced Anti-Liver Tumor Efficacy of Chimeric Antigen Receptor-T Cells via SATB1 Modulation
This article has 6 authors:
Tongbiao Zhao
Lin Zhang
Chenxi Cheng
Xinyi Bi
Jiani Cao
Xiaoyan Li
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up